These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 37795379)

  • 1. Why drug exposure is frequently associated with T-cell mediated cutaneous hypersensitivity reactions.
    Line J; Saville E; Meng X; Naisbitt D
    Front Toxicol; 2023; 5():1268107. PubMed ID: 37795379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
    Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions.
    Guvenir H; Arikoglu T; Vezir E; Misirlioglu ED
    Curr Pharm Des; 2019; 25(36):3840-3854. PubMed ID: 31696807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamazepine Induces Focused T Cell Responses in Resolved Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Cases But Does Not Perturb the Immunopeptidome for T Cell Recognition.
    Mifsud NA; Illing PT; Lai JW; Fettke H; Hensen L; Huang Z; Rossjohn J; Vivian JP; Kwan P; Purcell AW
    Front Immunol; 2021; 12():653710. PubMed ID: 33912179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adverse cutaneous reactions to drugs].
    Suástegui-Rodríguez I; Campos-Jiménez KI; Domínguez-Cherit J; Méndez-Flores S
    Rev Med Inst Mex Seguro Soc; 2018; 56(1):64-70. PubMed ID: 29368897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse cutaneous drug eruptions: current understanding.
    Hoetzenecker W; Nägeli M; Mehra ET; Jensen AN; Saulite I; Schmid-Grendelmeier P; Guenova E; Cozzio A; French LE
    Semin Immunopathol; 2016 Jan; 38(1):75-86. PubMed ID: 26553194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management [Formula: see text].
    Muntyanu A; Netchiporouk E; Gerstein W; Gniadecki R; Litvinov IV
    J Cutan Med Surg; 2021; 25(1):59-76. PubMed ID: 32746624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-associated antiepileptic drug-induced cutaneous adverse reactions.
    Mullan KA; Anderson A; Illing PT; Kwan P; Purcell AW; Mifsud NA
    HLA; 2019 Jun; 93(6):417-435. PubMed ID: 30895730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs and the skin: A concise review of cutaneous adverse drug reactions.
    Del Pozzo-Magaña BR; Liy-Wong C
    Br J Clin Pharmacol; 2022 Aug; ():. PubMed ID: 35974692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histopathology of cutaneous drug reactions].
    Ortonne N
    Ann Pathol; 2018 Feb; 38(1):7-19. PubMed ID: 29279184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vesicular Contact Reaction May Progress into Erythema Multiforme.
    Czarnecka-Operacz M; Jenerowicz D; Szulczyńska-Gabor J; Teresiak-Mikołajczak E; Szyfter-Harris J; Bowszyc-Dmochowska M
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):307-309. PubMed ID: 28128086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe cutaneous adverse drug reactions.
    Chung WH; Wang CW; Dao RL
    J Dermatol; 2016 Jul; 43(7):758-66. PubMed ID: 27154258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous drug reactions in the pediatric population.
    Noguera-Morel L; Hernández-Martín Á; Torrelo A
    Pediatr Clin North Am; 2014 Apr; 61(2):403-26. PubMed ID: 24636653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the HLA-B(*)58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions.
    Ng CY; Yeh YT; Wang CW; Hung SI; Yang CH; Chang YC; Chang WC; Lin YJ; Chang CJ; Su SC; Fan WL; Chen DY; Wu YJ; Tian YC; Hui RC; Chung WH;
    J Invest Dermatol; 2016 Jul; 136(7):1373-1381. PubMed ID: 26996548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making Rash Decisions in Epilepsy: Evaluating Hypersensitivity Reactions to Anti-seizure Medications.
    Bermeo-Ovalle A
    Epilepsy Curr; 2019; 19(2):96-98. PubMed ID: 30955419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions and organ damage: The skin.
    Marzano AV; Borghi A; Cugno M
    Eur J Intern Med; 2016 Mar; 28():17-24. PubMed ID: 26674736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
    Pavlos R; Mallal S; Ostrov D; Pompeu Y; Phillips E
    J Allergy Clin Immunol Pract; 2014; 2(1):21-33. PubMed ID: 24565765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin Resident Memory T Cells May Play Critical Role in Delayed-Type Drug Hypersensitivity Reactions.
    Schunkert EM; Shah PN; Divito SJ
    Front Immunol; 2021; 12():654190. PubMed ID: 34497600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin Allergy to Azole Antifungal Agents for Systemic Use: A Review of the Literature.
    Calogiuri G; Garvey LH; Nettis E; Romita P; Di Leo E; Caruso R; Butani L; Foti C
    Recent Pat Inflamm Allergy Drug Discov; 2019; 13(2):144-157. PubMed ID: 31538908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing for prevention of severe drug-induced skin rash.
    Alfirevic A; Pirmohamed M; Marinovic B; Harcourt-Smith L; Jorgensen AL; Cooper TE
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD010891. PubMed ID: 31314143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.